Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
Completed · Phase 1/Phase 2
Conditions studied: Lung Cancer
In brief
This study has two primary objectives. The first objective is to determine the maximal tolerated dose (MTD) that can be delivered with stereotactic radiosurgery in patients with inoperable malignant lung tumors. Once the MTD is established, the second objective is to determine the efficacy of radiosurgical ablation of lung tumors in terms of symptoms and radiographic responses.
Key facts
- Study ID
- NCT00238602
- Run by
- Stanford University
- People needed
- 48
- Starts
- 2000-03-01
- Expected to finish
- 2012-06-01
- Last updated by the study team
- 2012-07-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.